Write a SOAP note for a reproductive‑age patient (≈18‑35 years) presenting to discuss birth control, with regular menstrual cycles, no current pregnancy, and no contraindications to combined estrogen‑progestin contraception.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SOAP Note: Birth Control Consultation

Subjective

  • Chief Complaint: Patient presents requesting birth control counseling
  • Menstrual History: Regular menstrual cycles, last menstrual period date, cycle length and duration
  • Sexual History: Currently sexually active, number of partners, barrier method use, STI history
  • Contraceptive History: Prior contraceptive use, reasons for discontinuation, side effects experienced
  • Pregnancy History: Gravidity, parity, pregnancy intentions/timeline, breastfeeding status
  • Medical History: Screen specifically for CDC Category 3/4 contraindications to combined hormonal contraceptives (CHCs):
    • Migraine with aura
    • Smoking status (if age >35 years)
    • Hypertension or history of elevated blood pressure
    • Personal history of venous thromboembolism (VTE)
    • Diabetes with vascular complications
    • Coronary artery disease
    • Systemic lupus erythematosus with antiphospholipid antibodies
    • Breast cancer history
    • Active liver disease
    • Stroke history 1, 2
  • Medications: Current medications, particularly enzyme-inducing drugs (antiepileptics, rifampin)
  • Social History: Tobacco use (quantify pack-years if age >35), alcohol use
  • Review of Systems: Abnormal uterine bleeding, pelvic pain, dyspareunia, vaginal discharge

Objective

Per 2024 CDC guidelines, the following are NOT required before initiating contraception in healthy patients 1:

  • Class C (Not Required):
    • Pelvic examination
    • Papanicolaou test
    • STI screening (unless clinically indicated)
    • Lipid panel
    • Glucose testing
    • Liver function tests
    • Hemoglobin/hematocrit

Required Assessment:

  • Blood pressure measurement (essential for CHC initiation)
  • Weight/BMI documentation
  • General appearance and affect

Assessment

Healthy reproductive-age female requesting contraception, no contraindications to combined hormonal contraceptives identified.

Risk Stratification: No CDC Category 3 or 4 contraindications present; patient is appropriate candidate for all contraceptive methods including CHCs, progestin-only methods, and long-acting reversible contraceptives (LARCs) 1.

Plan

Contraceptive Counseling

Provide comprehensive counseling on all available methods, emphasizing efficacy and patient preference 3:

Tier 1 - Most Effective (>99% efficacy):

  • Long-acting reversible contraceptives (LARCs): Copper IUD, levonorgestrel IUD, etonogestrel implant
  • Advantages: Highest efficacy, no user-dependent adherence, cost-effective long-term
  • Can be initiated today without waiting for next menses 1, 3

Tier 2 - Highly Effective with Perfect Use (91-94% typical use):

  • Combined hormonal contraceptives: Pills, transdermal patch, vaginal ring
  • Progestin-only pills (POPs)
  • Depot medroxyprogesterone acetate (DMPA) injection

Tier 3 - Barrier Methods: Condoms, diaphragm (lower efficacy, recommend dual method for STI protection)

Recommended Approach for This Patient

Start combined oral contraceptive (COC) today using "Quick Start" method 3:

  • No need to wait for next menstrual period
  • Provide backup contraception instructions (barrier method for 7 days)
  • Prescribe 12-month supply to improve adherence and reduce costs 3

Anticipatory Guidance on Side Effects

Counsel on expected bleeding patterns 1:

  • Irregular spotting common in first 3 months with all hormonal methods
  • Typically improves with continued use
  • Management options if bothersome:
    • NSAIDs for 5-7 days
    • Reassurance and continued method use
    • Method change if persistent and unacceptable

Other common side effects:

  • Breast tenderness, nausea (usually resolve within 2-3 months)
  • Mood changes (monitor, consider method change if significant)
  • Headaches (distinguish from migraine with aura—absolute contraindication) 4, 5

Follow-Up Plan

  • Pregnancy test in 2-4 weeks if any uncertainty about current pregnancy status 1
  • Return visit PRN for side effects or method dissatisfaction
  • Annual blood pressure check for CHC users
  • Offer immediate method removal/change at any time per patient preference 1
  • Telemedicine or patient portal follow-up acceptable to reduce barriers 3

Prescribing Details

  • Specific COC formulation: [specify based on formulary and patient preference]
  • Dispense: 12-month supply (13 packs)
  • Refills: As needed
  • Instructions: Take one pill daily at same time; use backup contraception for first 7 days

Patient Education

  • Provide written information on chosen method
  • Review warning signs requiring immediate medical attention (ACHES mnemonic for CHCs: Abdominal pain, Chest pain, Headaches severe, Eye problems, Severe leg pain)
  • Emphasize that condoms should be used concurrently for STI prevention if at risk
  • Discuss that method can be discontinued at any time per patient preference 1

This approach prioritizes immediate contraceptive access using evidence-based "Quick Start" protocols, eliminates unnecessary barriers to care, and provides patient-centered counseling while ensuring appropriate medical screening for contraindications 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.